Tissue Regeneration News
-
Alfa Chemistry Shines as a Premier Recombinant Human Collagen Product Supplier
In the field of regenerative medicine and tissue engineering, the demand for collagen-based biomaterials is rapidly increasing. Collagen, the most abundant protein in the human body, plays a crucial role in maintaining the structure and function of various tissues. Recognizing the growing need for high-quality collagen products, Alfa Chemistry has emerged as a reliable supplier of recombinant ...
-
CELLINK and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence
CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned research institution, are pleased to announce their partnership to establish a 3D bioprinting Centre of Excellence. This partnership aims to facilitate the utilization of advanced bioprinting technologies and promote cutting-edge research in the fields of drug ...
By CELLINK
-
Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases
Juvena Therapeutics, Inc. (“Juvena”), a biotechnology company scaling a computational platform to map the therapeutic potential of secreted proteins, announced today that it has raised $41 million in an oversubscribed Series A, bringing its total funding to $50 million. The new funding will power the expansion of Juvena’s drug discovery platform and advance the company’s ...
-
CO2 laser treatment for acne scars
The scars left by acne are directly related to blood heat and dampness toxin. The accumulation of blood toxins in the body, the decline in the blood’s ability to carry and supply oxygen, and the poor blood microcirculation make skin cells unable to obtain the oxygen and nutrients required for normal metabolism and damage. Due to the normal metabolic environment of skin cells, and the ...
-
SANUWAVE Health Announces Issuance of Eleven New Patents Bringing the Company`s Total Number of Active Patents and Patent Applications to 150
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
-
KLISBio to present SILKBridge for peripheral nerve repair and its innovative silk-based tissue-engineered technology platform at 2022 Bio€quity Europe
Milan, Italy (May 11, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based multidisciplinary technology platform, announced its attendance to 2022 Bio€quity Europe. 2022 Bio€quity Europe will be held May 16 -18, 2022 in Milan – Italy. Antonio Alessandrino, CTO and Founder of KLISBio, will be presenting on ...
By KLISBio
-
NuShores welcomes a new Quality and Regulatory medical device professional to Little Rock
Little Rock, AR – NuShores Biosciences LLC (NuShores), founded and based in Little Rock, Arkansas, announced today that Mr. Sam Monk has accepted the position of Regulatory and Quality Manager and will move to Little Rock from the Seattle area. Mr. Monk will work closely with C-level management, research scientists, manufacturing, and our Quality and Regulatory team and services providers ...
-
InGeneron Publishes Overview on Current State and Potential of Regenerative Cell Therapy in Orthopedics
InGeneron, Inc., a clinical stage biotechnology company, announced the publication of a succinct scientific review of regenerative cell therapy, commonly called “stem cell therapy”, to treat orthopedic indications. This newly released paper, titled “Perspective: Why and how to use the body’s own stem cells for regeneration in musculoskeletal disorders: a primer“, was ...
-
KLISBio to feature engineered silk innovation at Biotech Showcase
Investors keen to get involved with a company on the forefront of human tissue regeneration will be interested to visit with KLISBio, an international medtech company bringing its silk-based biomedical technology and the first of their products, SILKBridge®, to the Biotech Showcase Jan. 10-19. KLISBio is leading a revolution in restorative surgical procedures using engineered silk ...
By KLISBio
-
KLISBio to feature engineered silk innovation at AAHS 2022
With the profound impact on patients’ quality of life, peripheral nerve injuries remain at the forefront of treatment challenges for orthopedic surgeons. That’s a driving force behind KLISBio’s SILKBridge®, a first-to-market solution for peripheral nerve repair. KLISBio will introduce SILKBridge® to attendees at the American Association for Hand Surgeons Annual Meeting ...
By KLISBio
-
BenevolentAI Achieves Second Major Collaboration Milestone With Novel Idiopathic Pulmonary Fibrosis Target Selected For AstraZeneca’s Portfolio
Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated by AstraZeneca Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to AstraZeneca’s portfolio in Q1 2021 London, 15 December 2021: BenevolentAI, a leading ...
By Benevolent
-
Biostage Hires David Green as Chief Executive Officer
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company with successful "first-in-human" experience in esophageal cancer and FDA approval to commence a clinical trial of its Biostage Esophageal Implant for esophageal disease, today announced it has hired David Green as its Chief Executive Officer and appointed Mr. Green as Chairman of the Board of Directors (the ...
-
Alkermes Announces the Appointment of Cato T. Laurencin, M.D., Ph.D. to its Board of Directors
Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Cato T. Laurencin, M.D., Ph.D., to the company's Board of Directors. Dr. Laurencin is a distinguished university professor, award-winning engineer, orthopaedic surgeon, scientist, administrator, and pioneer in the field of regenerative engineering. Dr. Laurencin is actively involved in mentoring and social ...
By Alkermes
-
TransVaginal Female Sexual and SUI Treatment
The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference. Treatment was offered to women suffering from stress urinary incontinence, sexual dysfunction or both conditions. Initial results are highly encouraging. Low ...
By DirexGroup
-
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has submitted its application to Japan’s Ministry of Health, Labour, and Welfare (MHLW) for approval to manufacture the Company’s RCT-01 cell therapy for ...
-
Biorez Announces David Hook as Vice President of Sales as it Prepares for BioBrace Commercialization
Biorez Inc., a New Haven late-stage start-up advancing tendon and ligament healing, today announced the appointment of David Hook as Vice President of Sales. Mr. Hook joins the Biorez team at an opportune time as the company approaches an expected 510(k) clearance, and limited commercial launch of its proprietary BioBrace Implant technology in the first half of 2021. “David is a ...
By Biorez Inc.
-
Amgen to Acquire Rodeo Therapeutics Corporation
Amgen Inc. (NASDAQ:AMGN) and Rodeo Therapeutics Corporation (Rodeo) today announced an agreement under which Amgen will acquire Rodeo, a privately held biopharmaceutical company based in Seattle that develops small-molecule therapies designed to promote regeneration and repair of multiple tissues. Rodeo's 15-PGDH program is a strong strategic fit with Amgen's inflammation portfolio and efforts to ...
By Amgen Inc.
-
Aspect Biosystems And Jsr Corporation Enter Collaboration To Develop Bioprinted Vascularized Tissues For Regenerative Medicine
Aspect Biosystems, a privately held biotechnology company pioneering the development of bioprinted therapeutics, is pleased to announce a new joint development program with JSR Corporation, a global leader in advanced materials innovation. This collaboration builds on the existing partnership between the two companies and will see the combining of Aspect’s proprietary microfluidic 3D ...
-
SANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership
SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that the Company has entered into a non-exclusive sales and marketing agreement with Ametus to market and sell the Company’s portfolio of wound care products in ...
-
Biorez Announces the Appointment of Nicholas Pachuda to Expanded Board of Directors
Biorez Inc., a New Haven start-up advancing tendon and ligament healing, today announced that medical device industry veteran, Nicholas Pachuda, has been appointed to its Board of Directors. A Podiatric Surgeon by training, Dr. Pachuda has spent the last 20 years in commercial leadership positions for DePuy Synthes (a Johnson & Johnson company), Arthrex, and a number of startups ...
By Biorez Inc.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you